Gerstein H - Search Results

1

Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease.

Sjaarda J, Gerstein H, Chong M, Yusuf S, Meyre D, Anand SS, Hess S, Paré G. Sjaarda J, et al. Among authors: gerstein h. J Am Coll Cardiol. 2018 Jul 17;72(3):300-310. doi: 10.1016/j.jacc.2018.04.067. Epub 2018 Jul 9. J Am Coll Cardiol. 2018. PMID: 30012324 Free article.

2

Summary of randomized trials of angiotensin converting enzyme inhibitors.

Yusuf S, Lonn E, Bosch J, Gerstein H. Yusuf S, et al. Among authors: gerstein h. Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):835-45. doi: 10.3109/10641969909061013. Clin Exp Hypertens. 1999. PMID: 10423106 Free article. Review.

3

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE).

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Anand SS, et al. Among authors: gerstein h. Lancet. 2000 Jul 22;356(9226):279-84. doi: 10.1016/s0140-6736(00)02502-2. Lancet. 2000. PMID: 11071182

4

Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE).

Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA. Anand SS, et al. Among authors: gerstein h. Indian Heart J. 2000 Nov-Dec;52(7 Suppl):S35-43. Indian Heart J. 2000. PMID: 11339439

5

Ramipril and the development of diabetes.

Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators. Yusuf S, et al. Among authors: gerstein h. JAMA. 2001 Oct 17;286(15):1882-5. doi: 10.1001/jama.286.15.1882. JAMA. 2001. PMID: 11597291 Clinical Trial.

6

Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).

Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, Montague PA, Lonn E. Anand SS, et al. Among authors: gerstein h. Lancet. 2001 Oct 6;358(9288):1147-53. doi: 10.1016/s0140-6736(01)06255-9. Lancet. 2001. PMID: 11597669

7

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

8

The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.

Gerstein HC, Anand S, Yi QL, Vuksan V, Lonn E, Teo K, Malmberg K, McQueen M, Yusuf S; SHARE Investigators. Gerstein HC, et al. Diabetes Care. 2003 Jan;26(1):144-9. doi: 10.2337/diacare.26.1.144. Diabetes Care. 2003. PMID: 12502671

9

Diagnostic strategies to detect glucose intolerance in a multiethnic population.

Anand SS, Razak F, Vuksan V, Gerstein HC, Malmberg K, Yi Q, Teo KK, Yusuf S. Anand SS, et al. Diabetes Care. 2003 Feb;26(2):290-6. doi: 10.2337/diacare.26.2.290. Diabetes Care. 2003. PMID: 12547851

10

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.

Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S. Mann JF, et al. J Am Soc Nephrol. 2003 Mar;14(3):641-7. doi: 10.1097/01.asn.0000051594.21922.99. J Am Soc Nephrol. 2003. PMID: 12595499 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters